海外の治験の状況「1」での検索結果
11240件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines
- Lateral Canthus Rhytides;Crow's Feet Lines;Lateral Canthus Rhytides;Crow's Feet Lines;Lateral Canthus Rhytides;Crow's Feet Lines;Lateral Canthus Rhytides;Crow's Feet Lines
- Belgium, Canada, United Kingdom, United States
- 2010-08-25
Not Recruiting
- Study of the efficacy and safety of BOTOX® in the treatment of facial wrinkles (crow's feet lines)
- Treatment of lateral canthal rhytides in the periorbital region (Crow's Feet Lines) br>MedDRA version: 13.1 Level: PT Classification code 10040954 Term: Skin wrinkling System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Belgium, Canada, United Kingdom, United States
- 2010-08-24
Not recruiting
- Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
- Lateral Canthal Lines;Crow's Feet;Facial Wrinkles
- United States
- 2010-05-12
Not recruiting
- A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
- Lateral Canthal Lines;Crow's Feet;Facial Wrinkles
- United States
- 2010-05-06
Not recruiting
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
- Kidney Failure;Secondary Hyperparathyroidism;Hyperphosphatemia;Hypercalcemia
- United States
- 2012-11-07
Authorised
- Study of oral PHA-848125AC in patients with malignant thymoma previously treated with multiple lines of chemotherapy
- Recurrent or metastatic, unresectable B3 thymoma or thymic carcinoma previously treated with multiple lines of chemotherapy;Therapeutic area: Diseases [C] - Cancer [C04]
- Italy, United States
- 2013-02-27
Recruiting
- A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines
- Rhytidosis Facialis
- United States
- 2015-11-30
Recruiting
- Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
- Pyruvate Dehydrogenase Complex Deficiency
- United States
- 2015-11-17
Not recruiting
- Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)
- Mesothelioma
- Australia, Belgium, Canada, Finland, France, Germany, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Turkey, United Kingdom, United States
- 2015-11-09
Not recruiting
- Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
- Glabellar Frown Lines
- United States
- 2015-10-22
Recruiting
- Comparing Ultrasound Guided PICC Line Insertion in Neonates With Standard Procedure
- Ultrasonography, Interventional;Peripheral Venous Catheterization
- Canada
- 2015-10-21
Not recruiting
- Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
- Skin Aging
- United States
- 2015-10-15
Not recruiting
- A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
- United States
- 2016-07-26
Recruiting
- Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I (BLESS I)
- Glabellar Rhytids
- United States
- 2016-06-23
Recruiting
- A Clinical Study Comparing Restylane® Silk and Belotero Balance® for the Treatment of Superficial, Vertical Perioral Lines
- Perioral Rhytids;Perioral Rhytids
- United States
- 2016-06-03
Recruiting
- Determinants of Resistance to First-line Therapy With an AI and Palbociclib for HR+ MBC
- Breast Cancer
- United States
- 2017-12-08
Recruiting
- Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment
- Patient Education
- United States
- 2017-11-27
Not recruiting
- VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults
- Invasive Aspergillosis;Invasive Pulmonary Aspergillosis
- Belgium, Canada, France, Germany, Korea, Republic of, United States
- 2017-10-27
Authorised
- Pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen as first line treatment for R/M HNSCC (KEYNOTE-669/ECHO-304)
- Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Brazil, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-10-24
Recruiting
- Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)
- Frown Lines
- Canada, United States
- 2018-12-21